Latest Breaking News On - Geoffrey mogilner - Page 1 : vimarsana.com

Olema Oncology to Participate in Upcoming Investor Conferences in June

SAN FRANCISCO, May 28, 2024 Olema Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for.

San franciscoUnited statesNew yorkUnited kingdomGeoffrey mogilnerOlema pharmaceuticals incGoldman sachsMarriott marquisLoews miami beach hotel inGlobal healthcare conferenceAnnual global healthcare conferenceLoews miami beach hotelVice presidentInvestor relations

Olema Oncology Announces Promising New Data for

Olema Oncology Announces Promising New Data for
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesUnited kingdomGeoffrey mogilnerSeanp bohenCompany investor webcastExchange commissionBreast cancer annual congressDrug administrationOlema pharmaceuticals incSecurities exchangeCancer annual congressEstrogen receptor positiveHuman epidermal growth factor receptorMetastatic breastChief executive officer

Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress - Olema Pharmaceuticals (NASDAQ:OLMA)

Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress - Olema Pharmaceuticals (NASDAQ:OLMA)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSan franciscoGeoffrey mogilnerOlema pharmaceuticals incBreast cancer annual congressEuropean society for medical oncologyDrug administrationCompany investor webcastEuropean societyMedical oncologyCancer annual congressInvestor webcastFast trackMedia contactVice president

Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress

Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSan franciscoGeoffrey mogilnerEuropean society for medical oncologyBreast cancer annual congressDrug administrationOlema pharmaceuticals incCompany investor webcastOlema pharmaceuticalsEuropean societyMedical oncologyCancer annual congressInvestor webcastFast trackMedia contact

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, May 02, 2024 Olema Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for.

United statesSan franciscoUnited kingdomGeoffrey mogilnerCompensation committee of olema board directorsOlema pharmaceuticals incCompensation committeeNasdaq listing ruleOlema pharmaceuticalsVice presidentInvestor relations